Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
about
Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro.The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.Longitudinal study of Plasmodium pathogens identifies new loci associated with artemisinin resistance.Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on Plasmodium Falciparum Drug Sensitivity-Associated Haplotypes in Uganda.A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineInitiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study.Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.Influence of the pfmdr1 Gene on In Vitro Sensitivities of Piperaquine in Thai Isolates of Plasmodium falciparum.Combating multidrug-resistant Plasmodium falciparum malaria.Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.The Plasmodium berghei RC strain is highly diverged and harbors putatively novel drug resistance variants.Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.Changing antimalarial drug sensitivities in Uganda.A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malImpact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.How to tackle antimalarial resistance?The threat of artemisinin resistant malaria in Southeast Asia.Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar.The prevalence, incidence and prevention of Plasmodium falciparum infections in forest rangers in Bu Gia Map National Park, Binh Phuoc province, Vietnam: a pilot study.malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is Endemic.Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.Therapeutic Response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia.Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance.The emergence and spread of kelch 13 mutations associated with artemisinin resistance in Plasmodium falciparum parasites in twelve Thai provinces from 2007 - 2016.Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar.Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study.Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.Inactivation of Plasmepsin 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine.Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.Plasmepsins on the antimalarial hit list.A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants.Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association with Artemisinin Resistance.Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
P2860
Q33555297-267D9C11-6E59-4CAD-8071-CF7DC340C955Q33607319-913380E3-C3E9-46AA-BC8A-D278C65F26D9Q33617728-164E9505-50EA-4BEC-A3B6-23C5923492DBQ33629027-0E7001F5-41A9-407B-AC16-9610FFE5C491Q33654512-D28001EE-F5BF-4975-AAC6-A1A6CF87ADD6Q33662226-0A500941-A677-4531-8BF6-8E3530D95221Q33668137-BE975B36-123D-4023-BB83-BC5D2663F1B5Q33729200-C50DAAA1-9218-4611-A44B-811355ABA790Q33732740-A0235E64-1244-4162-AE9C-9B8BF1AE4E9EQ37586458-FB400815-113C-4A19-A80D-8E0DCFFA707CQ39280599-9DC159B8-DDFD-4BBD-BD47-714E80E5AE3BQ39281073-72A4D08A-0B82-454D-8926-E30678A86580Q39350422-0914D009-B45E-4DD5-87EA-389B094F7A80Q40064790-B4DA8FBF-04BA-48A8-8B7A-A62D591B936AQ40106428-36242B80-B796-4545-87E4-5327F7BC0DDEQ41911761-5B3AFF58-D0C8-4536-8391-28C00782D2E1Q41911927-B818B0ED-2762-4999-8D76-6F32328B6E14Q41911931-DC04BD68-A6BA-4935-B8B6-E835248C3422Q41989960-CBB656B5-9A1A-49DB-B99F-F4AD199AE75AQ41992238-731100A9-0DDF-452F-9163-26497354B190Q42101487-807181B7-DFE0-4CA1-ADE3-93C304B1A6AEQ42343414-D1B1D97E-2333-4F75-9171-3872FB93548DQ47108422-9C96C291-1FBB-449E-A8C5-D343366B4DC2Q47111312-56017CBC-A17A-40DB-A91C-8C4FE97369E8Q47134819-D44B866C-933D-4579-AEB2-014DC1059A8FQ48018991-8CE2FE7F-D4A8-42FC-9CF4-D70EC20641D6Q48019828-CB34AD85-CBE6-4A0C-8741-84CB6DA7BB60Q48022379-B4F94A0D-1729-48E9-BBFF-E9F69F9365C9Q48023117-09030708-A11B-4D99-A8F7-084CB7D0DE94Q48023803-47E3209A-F830-453F-A31B-03DA5939BBEAQ48023924-484DB463-1427-4CC6-9A11-3B4AD88E3371Q48506962-450EBA79-C8D5-4597-B117-4020FE2E2629Q49843529-67553A1A-12ED-47A1-8977-F5868FD9C805Q50028083-9CB85821-B317-4AF0-91D2-E46C9B3B6E9BQ50052786-F668F8CD-1619-48E2-BD2B-0CFB30E3D3E7Q50092308-6F2239FE-B5D3-42AF-BDE4-5566C601274DQ52565801-BD0BA3C4-1633-4AFE-8C03-9BA26C059A85Q52575118-28B199A7-B3A8-4AD9-A4EB-B60C76E0F229Q52585854-769F7F53-D84E-4F00-A758-29B598B3CD2FQ52609473-BCE66A10-1A45-4907-8DF8-6AE1E6DAC74E
P2860
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Genetic markers associated wit ...... pe-phenotype association study
@ast
Genetic markers associated wit ...... pe-phenotype association study
@en
Genetic markers associated wit ...... e-phenotype association study.
@nl
type
label
Genetic markers associated wit ...... pe-phenotype association study
@ast
Genetic markers associated wit ...... pe-phenotype association study
@en
Genetic markers associated wit ...... e-phenotype association study.
@nl
prefLabel
Genetic markers associated wit ...... pe-phenotype association study
@ast
Genetic markers associated wit ...... pe-phenotype association study
@en
Genetic markers associated wit ...... e-phenotype association study.
@nl
P2093
P2860
P50
P921
P1476
Genetic markers associated wit ...... pe-phenotype association study
@en
P2093
Aaron T Neal
Chanaki Amaratunga
Eleanor Drury
Jacob Almagro-Garcia
Jim Stalker
Olivo Miotto
Richard D Pearson
Rick M Fairhurst
Seila Suon
P2860
P304
P356
10.1016/S1473-3099(16)30409-1
P577
2016-11-03T00:00:00Z